Alexandria real estate equities, inc., at the vanguard of the life science industry, providing high-quality office/laboratory space to meet historic-high demand, reports: 4q21 and 2021 net income per share - diluted of $0.47 and $3.82, respectively; 4q21 and 2021 ffo per share - diluted, as adjusted, of $1.97 and $7.76, respectively